When Is Metabolic Surgery Considered in Type 2 Diabetes?

It is well established that bariatric surgery produces weight loss. Less widely recognised is that its effect on blood glucose begins before weight loss occurs. This observation led to the definition of "metabolic surgery" alongside obesity surgery.

1. What Is Metabolic Surgery?

Technically the same surgical procedures are involved, most often gastric bypass and sleeve gastrectomy. The distinction lies in the primary objective:

• In obesity surgery the primary objective is weight loss.
• In metabolic surgery the primary objective is control of type 2 diabetes and accompanying metabolic disturbance.

2. Why Does the Effect Precede Weight Loss?

In some patients, improvement in glycaemic control is observed within days of gastric bypass, before meaningful weight loss has occurred. This cannot be explained by reduced caloric intake alone.

Current understanding points to gut hormones:

• Incretin response: Earlier delivery of nutrients to the distal small intestine increases release of hormones supporting insulin secretion, such as GLP-1.
• Ghrelin levels: Levels of the appetite-stimulating hormone secreted by the stomach are altered.

The effect is hormonal as much as mechanical. Important Note: The GLP-1 based diabetes and obesity medications that have become widespread in recent years mimic broadly the same hormonal pathway pharmacologically.

3. In Which Patients Is It Considered?

• BMI 40 and above: Surgery is strongly considered in the presence of diabetes.
• BMI 35–39.9: Considered particularly in type 2 diabetes not controlled on medical therapy.
• BMI 30–34.9: May be considered where glycaemic targets are not achieved despite appropriate pharmacological treatment and lifestyle modification.

Two further criteria are as decisive as BMI in the assessment:

• Duration of diabetes: The more recent the disease, the more pronounced the expected metabolic response.
• Pancreatic beta cell reserve: Preserved insulin-producing capacity favours the response. Expectations should be set differently in patients who have used insulin for many years.

Important Note: Type 1 diabetes is not assessed within this scope. There the pathology is absent insulin production, not insulin resistance.

4. Does Diabetes Resolve Completely?

The term used in the literature is remission: blood glucose remaining within the target range without antidiabetic therapy. Remission is observed in some patients and not in others; in a proportion of those in whom it is observed, diabetes may recur over subsequent years.

The principal determinants of outcome are:

• Duration of diabetes before surgery
• Pancreatic reserve
• The surgical procedure performed
• Whether weight control is sustained postoperatively

Important Note: The outcomes consistently reported in the literature are reduced medication requirement, improved glycaemic control and consequently reduced long-term complication risk. These outcomes vary between individuals.

5. Postoperative Treatment Adjustment

• Medication and insulin dosing: As blood glucose may fall rapidly, antidiabetic therapy is monitored closely after surgery and is often reduced early. This adjustment is made together with endocrinology; patients should not discontinue medication on their own initiative.
• Vitamin and mineral monitoring: As absorption is reduced following gastric bypass, B12, iron, vitamin D and calcium levels are monitored lifelong.

Frequently Asked Questions

Can insulin be stopped completely after metabolic surgery?

In some patients the need for insulin may disappear; in others it continues at a lower level. This depends particularly on the duration of diabetes and the insulin-producing capacity of the pancreas. Medication and insulin adjustments must be made together with endocrinology.

With GLP-1 medications available, is metabolic surgery still needed?

GLP-1 based medications have become an important option in treating diabetes and obesity. Surgery and medication are not alternatives to each other but options with different places in different patients. A medication's effect lasts while it is taken, whereas surgery is a permanent anatomical change. The choice is made jointly according to disease severity, patient preference and response to treatment.

Which metabolic procedure is more effective for diabetes?

Gastric bypass often stands out in diabetes because of its effect on gut hormones. Sleeve gastrectomy also has a marked metabolic effect. The choice depends on the presence of reflux, eating habits and the patient's general condition.

Can diabetes return after surgery?

Yes. In a proportion of patients who achieve remission, diabetes can recur over the years. Maintaining weight loss and regular follow-up reduce this risk, which is why glucose monitoring continues after surgery.

Conclusion

Metabolic surgery is not a first-line treatment for type 2 diabetes. It does not arise before medical therapy, dietary modification and physical activity have been tried. Where glycaemic control cannot be achieved despite these steps and BMI lies within the appropriate range, however, failing to consider the surgical option would equally represent an incomplete approach.

Assessment is undertaken jointly by endocrinology, dietetics and surgery. At the centre of the decision lie the patient's disease history and their capacity to sustain long-term follow-up.

References

• Rubino F, Nathan DM, Eckel RH, et al. Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations. Diabetes Care, 2016.
• Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes. New England Journal of Medicine, 2017.
• Eisenberg D, Shikora SA, Aarts E, et al. 2022 ASMBS and IFSO: Indications for Metabolic and Bariatric Surgery. Surgery for Obesity and Related Diseases, 2022.
• American Diabetes Association. Standards of Care in Diabetes — Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes.